Neutral Buoyancy Microelectrode for Tissue Displacement
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing medical microelectrodes face challenges in maintaining mechanical stability within soft tissues like the brain and spinal cord, leading to displacement and potential tissue damage due to movements, which affects signal recording and stimulation efficacy.
Innovation Solution
The development of a 'floating' microelectrode design that approximates the specific weight of the surrounding tissue, allowing it to follow tissue movements and remain stable through inertia, while optionally incorporating anchoring means for withdrawal, using materials like silver alloy and polymer foams to ensure physical stabilization without causing tissue damage.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional microelectrodes are implanted into soft tissue, then they can record and stimulate brain structures, but they become displaced due to tissue movements such as respiration, heart beat, and skeletal movements
Solution Approach 1:
The patent changes the density parameter of the electrode to match the surrounding tissue (approximately 1.04 g/cm³). This is achieved by using a tubular structure with specific wall thickness and material composition (silver alloy with copper) that provides the desired density. By matching the tissue density, the electrode becomes neutrally buoyant and follows tissue movements without displacement, resolving the contradiction between maintaining spatial relationship and allowing tissue movement.
Solution Approach 2:
The patent applies the counterweight principle by balancing the electrode's weight against the buoyant force of the surrounding tissue. The electrode's density is specifically designed to equal tissue density, creating a state of neutral buoyancy where gravitational force and buoyant force balance each other. This prevents the electrode from sinking or floating within the tissue, maintaining stable spatial relationships during physiological movements.
2Reliability
If the electrode is made rigid to maintain stability, then it resists displacement, but it causes tissue damage during insertion and withdrawal
Solution Approach 1:
The patent employs a flexible thin-walled tubular structure with wall thickness of 3-10 μm made from silver alloy with copper. This thin-walled design allows the electrode to be sufficiently rigid to maintain its shape and resist displacement, yet flexible enough to minimize tissue damage during insertion and withdrawal. The flexibility of the thin wall enables the electrode to conform to tissue movements without causing mechanical injury.
Solution Approach 2:
The patent uses a composite material structure consisting of a silver alloy tube with copper reinforcement. This composite design provides the necessary mechanical strength and rigidity to maintain electrode stability while the overall thin-walled construction reduces tissue damage. The combination of materials optimizes both structural integrity and biocompatibility.
3Object-affected harmful factors
If the electrode is made flexible to reduce tissue damage, then it causes less injury, but it becomes more susceptible to displacement from tissue movements
Solution Approach 1:
The patent changes the density parameter of the flexible electrode to match tissue density (approximately 1.04 g/cm³). By adjusting the material composition and wall thickness of the silver alloy tube, the electrode achieves neutral buoyancy. This allows the flexible electrode to remain stable and follow tissue movements without displacement, resolving the contradiction between flexibility and stability.
4Reliability
If the electrode density is matched to tissue density to achieve neutral buoyancy, then it resists displacement, but it requires precise control of material composition and wall thickness
Solution Approach 1:
The patent specifies a target density of approximately 1.04 g/cm³ and provides guidance on achieving this through material selection and dimensional design. The use of silver alloy with copper and specific wall thickness ranges (3-10 μm) offers a practical manufacturing target that balances precision requirements with fabrication feasibility.
Solution Approach 2:
The patent applies local quality by varying the wall thickness distribution and material composition in different sections of the tubular electrode. The wall thickness is optimized locally to achieve the desired density while maintaining structural integrity. This allows precise control of the electrode's buoyancy characteristics without requiring uniform precision throughout the entire structure.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The microelectrode effectively resists displacement within soft tissues, maintaining signal integrity and reducing tissue damage, enabling long-term recordings and stimulation in delicate areas like the brain and spinal cord.
Implementation Method 1
The microelectrode is resistant to displacement within the tissue by inertia
Data Source
Figure 1~4
Figure 5~8
Figure 9a~9e
AI summary
A medical microelectrode has a front end, a rear end and a density at 20 °C of from 0.80 to 1.15. The electrode comprises any of: electrically conductive tubiform lead com prising or consisting of a metal and/or an electrically conductive polymer, the lead having an outer surface and a sealed lumen; electrically conductive wire lead comprising or consisting of a metal and/or an electrically conductive polymer, the lead having a surface and a buoyant element of a density of less than 1.0 attached to the surface.